Diamorphine Hydrochloride Injection BP 30mg
Lyophilised powder for reconstitution for injection...
Read more
addressing unmet medical needs
Welcome to Auralis
Auralis is an innovative and agile specialist Pharmaceutical company with strong development, technical and commercial capabilities. We have a specific focus on ensuring the availability and appropriate presentation of important medicinal products which will address unmet medical needs.
We have a proven track record of successfully taking complex products from conception to commercialisation. Supported by an established network of global partners Auralis has a highly scalable operation and the ability to leverage class leading solutions.
Complementing our current commercial products we have a strong development pipeline, specifically in the areas of Critical Care, Paediatrics and Addiction.
News
Developing Safe Medicines for Children
November 2009: The safety aspects of developing new medicines for children were the main topic of a ...
Read more
Auralis Signs Distribution Agreement for ‘Specials’ Medicines
November 2009: Auralis has contracted distribution of its unlicensed ‘specials’ products to The ...
Read more
Clinical Trial of Buccolam™ Treatment for Childhood Epilepsy
Auralis Limited (“Auralis”), a specialist pharmaceutical company, and Therakind Limited (“Ther...
Read more